JEMILAT MOMOH: Open Payments
NPI 1700396082 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 2 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $110 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $140 |
| Otsuka America Pharmaceutical, Inc. | 1 | $60 |
Products named: REPATHA, REXULTI.
Industry payments across TX — which companies pay providers there.
